PR

ProBiotix Health Plc

Develops and supplies probiotic solutions for cardiometabolic health and healthy aging.

PBX | Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BLNBFR86
LEI:
98450048683CF0388C30
Country:
United Kingdom
Address:
First Floor Zucchi Suite, WF4 1AB Wakefield

Description

ProBiotix Health Plc is a life sciences company that develops and supplies scientifically validated, probiotic-based microbiome solutions. The company specializes in formulations for cardiometabolic health, targeting conditions related to cholesterol, blood pressure, and vascular health, as well as healthy aging. Its core technology is LPLDL®, a patented and trademarked Lactobacillus plantarum strain demonstrated in human clinical trials to be effective in managing key cardiometabolic markers. ProBiotix Health offers its technology as both a raw ingredient and in finished product formulations, such as the YourBiotix and CholBiome® lines, for the global dietary supplement market. The company's approach is rooted in extensive research and development, conducted in collaboration with universities and scientific advisors to ensure product efficacy and safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-03 08:30
Move from Access to Apex Segment of Aquis
English 12.1 KB
2025-10-23 08:00
Appointment of Aquis Corporate Adviser
English 10.1 KB
2025-10-20 08:00
New Commercial Partnership in Australia
English 16.5 KB
2025-10-14 15:00
Director/PDMR Shareholding
English 20.3 KB
2025-10-14 08:00
New Commercial Partnership in Sweden
English 15.7 KB
2025-10-13 08:00
Q3 2025 Trading Update and Grant of Options
English 14.2 KB
2025-09-08 08:00
Unaudited Interim Results to 30 June 2025
English 206.3 KB
2025-07-15 08:00
Trading Update and Notice of Results
English 16.1 KB
2025-06-27 13:35
Result of AGM and Notice of Trading Update
English 10.7 KB
2025-06-09 17:15
PDMR Shareholding
English 17.0 KB
2025-06-05 18:30
Notice of Annual General Meeting - Clarification
English 10.3 KB
2025-05-30 08:01
Director/PDMR Shareholding
English 28.3 KB
2025-05-30 08:00
Notice of AGM
English 10.4 KB
2025-05-29 08:00
Final Results
English 708.9 KB
2025-05-07 08:00
Notice of Results and Investor Presentation
English 11.8 KB

Automate Your Workflow. Get a real-time feed of all ProBiotix Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ProBiotix Health Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ProBiotix Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.